Status:
COMPLETED
Ultrasound-guided Genicular Nerve Block for Total Knee Arthroplasty.
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Pain
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The hypothesis is to demonstrate the analgesic non-inferiority of the ultrasound-guided geniculate nerve block when compared to the local infiltration analgesia (LIA). It is expected to maintain the q...
Detailed Description
The main objective is to demonstrate that the ultrasound-guided geniculate nerve block provides not-inferior analgesia to LIA in patients undergoing primary total knee arthroplasty (TKA) in the first ...
Eligibility Criteria
Inclusion
- Subjects scheduled for primary elective total knee arthroplasty
- American Society of Anesthesiologists Physical Status I-III
- BMI 18-40 kg/m2
Exclusion
- Inability to cooperate with protocol
- Allergy to any medication of protocol
- Contraindication to peripheral nerve block (e.g. local or systemic infection, neurologic deficit or disorder, previous trauma or surgery to ipsilateral knee, etc.)
- Revision or prothesis replacement knee surgery
- Chronic opioid consumption (daily morphine equivalent of \>30 mg for at least four weeks prior to surgery)
- Bleeding diathesis or non-pharmacological coagulopathy
Key Trial Info
Start Date :
December 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04681547
Start Date
December 15 2020
End Date
April 30 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona
Barcelona, Spain, 08036